Pharmathen S.a. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Pharmathen S.a.

Patent Number:
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
Opposition Date:
Oct 12, 2022

Latest patents of Pharmathen S.a. opposed by its competitors

Patent:
Grant Date:
Feb 8, 2023
Title:
Preparation Of Polylactide-Polyglycolide Microparticles Having A Sigmoidal Release Profile
Oppositions:
1

Competitors of Pharmathen S.a.

ALKERMES PHARMA IRELAND LIMITED

NOVARTIS AG

Want to track Pharmathen S.a.?

Feel free to send us a message here and we will get back to you